Menu
Home
Forums
New posts
Search forums
What's new
Featured content
New posts
New media
New media comments
New resources
Latest activity
Media
New media
New comments
Search media
Resources
Latest reviews
Search resources
Misc
Log in
Register
What's new
Search
Search
Search titles only
By:
New posts
Search forums
Menu
Log in
Register
Install the app
Install
Home
Forums
Labrish
Nyuuz
Global Fund raises $11.34 billion, falls short of $18 billion target
JavaScript is disabled. For a better experience, please enable JavaScript in your browser before proceeding.
You are using an out of date browser. It may not display this or other websites correctly.
You should upgrade or use an
alternative browser
.
Reply to thread
Message
[QUOTE="Munyaradzi Mafaro, post: 72443, member: 636"] A Geneva-based organization combating infectious diseases secured commitments totaling $11.34 billion during a Johannesburg fundraising conference, falling short of its $18 billion objective for operations through 2029. The Global Fund to Fight AIDS, Tuberculosis, and Malaria acknowledged the difficult landscape for international health financing after Washington reduced development assistance under the Trump administration. Executive director Peter Sands emphasized that recipient nations must accelerate their transition toward financial independence while cautioning against overly rapid withdrawals that could undermine disease control achievements. American officials contributed $4.6 billion compared with the $6 billion commitment made during the previous fundraising cycle hosted by former President Biden. The organization plans to reduce administrative expenses by one-fifth next year and has already notified grant recipients about reduced allocations through 2026 due to revenue shortfalls. [/QUOTE]
Insert quotes…
Name
Post reply
Home
Forums
Labrish
Nyuuz
Global Fund raises $11.34 billion, falls short of $18 billion target
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.
Accept
Learn more…
Top